NCT01617382 Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
| NCT ID | NCT01617382 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Peritoneal Carcinomatosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 125 participants |
| Start Date | 2012-05 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 125 participants in total. It began in 2012-05 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC.
Eligibility Criteria
Inclusion Criteria: * Patients with peritoneal carcinomatosis of colorectal origin, patients with pseudomyxoma peritonei (type DPAM or PMCA) and patients with peritoneal mesothelioma who are planned to undergo cytoreductive surgery and HIPEC because of a peritoneal surface malignancy
Contact & Investigator
André JL D'Hoore, PhD
PRINCIPAL INVESTIGATOR
University Clinics Gasthuisberg Department of Abdominal Surgery
Frequently Asked Questions
Who can join the NCT01617382 clinical trial?
This trial is open to participants of all sexes, studying Peritoneal Carcinomatosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01617382 currently recruiting?
Yes, NCT01617382 is actively recruiting participants. Contact the research team at isabelle.terrasson@uzleuven.be for enrollment information.
Where is the NCT01617382 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT01617382 clinical trial?
NCT01617382 is sponsored by Universitaire Ziekenhuizen KU Leuven. The principal investigator is André JL D'Hoore, PhD at University Clinics Gasthuisberg Department of Abdominal Surgery. The trial plans to enroll 125 participants.